Dolan BP, Gibbs KD Jr, and Ostrand-Rosenberg S.  2006.  Dendritic cells cross-dressed with peptide MHC class I complexes prime CD8+ T cells.  J. Immunol. 177:6018-6124.
[Abstract]

Bosch JJ, Thompson JA, Srivastava MK, Iheagwara UK, Murray TG, Lotem M, Ksander BR and Ostrand-Rosenberg S.  2007.  MHC class II-transduced tumor cells originating in the immune-privileged eye prime and boost CD4(+) T lymphocytes that cross-react with primary and metastatic uveal melanoma cells.  Cancer Res. 67:4499-4506.
[Abstract]

Sinha P, Clements VK, Fulton AM and Ostrand-Rosenberg S.  2007.  Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells.  Cancer Res. 67:4507-4513.
[Abstract]

Sinha P, Clements VK, Bunt SK, Albelda SM and Ostrand-Rosenberg S.  2007.  Cross-talk between myeloid-derived suppressor cells and macrophages subverts tumor immunity toward a type 2 response.  J. Immunol. 179:977-983.
[Abstract]

Thompson JA, Srivastava MK, Bosch JJ, Clements VK, Ksander BR and Ostrand-Rosenberg S.  2007.  The absence of invariant chain in MHC II cancer vaccines enhances the activation of tumor-reactive type 1 CD4(+) T lymphocytes.  Cancer Immunol. Immunother.  Epub ahead of print.
[Abstract]